- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/62 - DNA sequences coding for fusion proteins
Patent holdings for IPC class C12N 15/62
Total number of patents in this class: 10168
10-year publication summary
|
202
|
316
|
371
|
646
|
537
|
592
|
798
|
845
|
764
|
723
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20268 |
150 |
| The Trustees of the University of Pennsylvania | 4376 |
82 |
| President and Fellows of Harvard College | 6030 |
74 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2903 |
71 |
| The Board of Trustees of the Leland Stanford Junior University | 6526 |
58 |
| The General Hospital Corporation | 4797 |
57 |
| Regeneron Pharmaceuticals, Inc. | 4426 |
57 |
| Sangamo Therapeutics, Inc. | 419 |
56 |
| The Broad Institute, Inc. | 1869 |
54 |
| Centre National de La Recherche Scientifique | 10666 |
48 |
| National Research Council of Canada | 1549 |
42 |
| F. Hoffmann-La Roche AG | 7934 |
40 |
| Board of Regents, The University of Texas System | 5927 |
39 |
| Massachusetts Institute of Technology | 10130 |
38 |
| The Johns Hopkins University | 5752 |
35 |
| Novartis AG | 10626 |
34 |
| JCR Pharmaceuticals Co., Ltd. | 221 |
34 |
| Immatics Biotechnologies GmbH | 1158 |
32 |
| Monsanto Technology LLC | 8271 |
31 |
| University of Washington | 2378 |
31 |
| Other owners | 9105 |